Market Overview:
The global bioprocessing systems market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for biopharmaceuticals and rising investment in R&D for novel drug discovery. In addition, growing awareness about biosimilars and their benefits is also contributing to the growth of the market. On the basis of type, the global bioprocessing systems market can be segmented into upstream, downstream, single use, and integrated systems. The downstream segment is expected to account for a major share of the global market during the forecast period owing to its wide applicability in various stages of drug development process such as purification, formulation development, filling & finishing operations etc. Based on application,the global bioprocessing systemsmarket can be divided into vaccine development ,cell therapy and plant cell cultivation ,filters ,tissue engineering ,biosensors ,bioreactors and mixers plasma fractionation chromatography bio-therapeutic molecule production .The vaccine development segment is projectedto registerthe highest CAGR duringthe forecast period owingto increasing demandfor betterand safervaccines .
Product Definition:
Bioprocessing systems are used to convert raw materials into products that can be used by the body. This includes converting food into energy and nutrients, as well as producing medicines and other valuable products. The importance of bioprocessing systems is that they allow us to produce essential goods and services while minimizing environmental impact.
Upstream:
Upstream is a software system that provides process-driven solutions for upstream processing in bioprocessing. It has been developed by Wockhardt Ltd., India based multinational company, which also owns Genpact Ltd. and Infosys Ltd. The system’s primary function is to automate the process of pre-filtration, cell culture seeding, sterile filtration & media preparation along with providing real time data for downstream analysis through its integrated software viz.
Downstream:
Downstream is the part of bioprocessing which is carried out after fermentation has occurred. It includes processes such as purification, concentration, and formulation into commercial products. The downstream process can be done in two ways i.e., directly or indirectly dependent on the type of microorganism used for production (bacteria or yeast).
Biopharmaceutical companies are increasingly using upstream processing to increase output.
Application Insights:
Vaccine development held the largest market share in 2017 and is anticipated to grow at a lucrative CAGR over the forecast period. The rising prevalence of infectious and chronic diseases, especially in developing regions such as Central & South America, Africa, and Asia Pacific is expected to be a key factor driving bioprocessing systems demand for vaccine development.
The cell therapy segment also holds significant market share and is projected to grow at a healthy CAGR during the forecast period. Growing awareness regarding advanced treatments for various life-threatening diseases through stem cells therapies has led to an increased focus on research activities across various institutions globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as local presence of major players, advanced research infrastructure and high healthcare expenditure in the region. Moreover, increasing focus on drug discovery and development is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising bioprocessing activities mainly due to outsourcing by North America and Europe coupled with growing R&D initiatives undertaken by pharmaceutical companies for drug discovery & development processes. In addition, favorable government policies aimed at promoting manufacturing output are also expected favorably impact regional demand over the next eight years (2018-2030). For instance, Japan’s Ministry of Health, Labor & Welfare (MHLW) has established a new regulatory framework for medical devices that includes pre- and post-market surveillance systems for quality control purposes under JMSDF (Japan Medical Systems Devices Evaluation Federation).
Growth Factors:
- Increasing demand for biopharmaceuticals: The global biopharmaceutical market is expected to grow at a CAGR of 10.5% from 2016 to 2021, reaching a value of 2.8 billion by 2021. This growth is primarily attributed to the increasing prevalence of chronic diseases, rising awareness about preventive healthcare, and technological advancements in the field of biotechnology.
- Growing demand for vaccines: The global vaccine market is expected to grow at a CAGR of 9% from 2016 to 2021, reaching a value of billion by 2021. This growth can be attributed to the increasing incidence of infectious diseases, growing public-private investments in vaccine research and development (R&D), and expanding government initiatives for vaccination programs across emerging markets
- one out five people will be aged 60 years or above globally which would drive the demand for better healthcare services including diagnosis & treatment options as well as therapies such as biosimilars which offer cost benefits over innovator drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioprocessing Systems Market Research Report
By Type
Upstream, Downstream, Single Use, Integrated
By Application
Vaccine Development, Cell Therapy and Plant Cell Cultivation, Filters, Tissue Engineering, Biosensors, Bioreactors and Mixers, Plasma Fractionation, Chromatography, Bio-therapeutic Molecule Production
By Companies
Lonza, Pall Corporation, GE Healthcare, Nordson MEDICAL's, Thermo Fisher Scientific, EMD Millipore Corporation, PBS Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Bioprocessing Systems Market Report Segments:
The global Bioprocessing Systems market is segmented on the basis of:
Types
Upstream, Downstream, Single Use, Integrated
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Vaccine Development, Cell Therapy and Plant Cell Cultivation, Filters, Tissue Engineering, Biosensors, Bioreactors and Mixers, Plasma Fractionation, Chromatography, Bio-therapeutic Molecule Production
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lonza
- Pall Corporation
- GE Healthcare
- Nordson MEDICAL's
- Thermo Fisher Scientific
- EMD Millipore Corporation
- PBS Biotech
Highlights of The Bioprocessing Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Upstream
- Downstream
- Single Use
- Integrated
- By Application:
- Vaccine Development
- Cell Therapy and Plant Cell Cultivation
- Filters
- Tissue Engineering
- Biosensors
- Bioreactors and Mixers
- Plasma Fractionation
- Chromatography
- Bio-therapeutic Molecule Production
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioprocessing Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioprocessing systems are used to process biological materials. These systems can be used to extract valuable compounds from a variety of sources, including plants, animals, and microorganisms.
Some of the key players operating in the bioprocessing systems market are Lonza, Pall Corporation, GE Healthcare, Nordson MEDICAL's, Thermo Fisher Scientific, EMD Millipore Corporation, PBS Biotech.
The bioprocessing systems market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioprocessing Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioprocessing Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioprocessing Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioprocessing Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioprocessing Systems Market Size & Forecast, 2018-2028
4.5.1 Bioprocessing Systems Market Size and Y-o-Y Growth
4.5.2 Bioprocessing Systems Market Absolute $ Opportunity
Chapter 5 Global Bioprocessing Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bioprocessing Systems Market Size Forecast by Type
5.2.1 Upstream
5.2.2 Downstream
5.2.3 Single Use
5.2.4 Integrated
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bioprocessing Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bioprocessing Systems Market Size Forecast by Applications
6.2.1 Vaccine Development
6.2.2 Cell Therapy and Plant Cell Cultivation
6.2.3 Filters
6.2.4 Tissue Engineering
6.2.5 Biosensors
6.2.6 Bioreactors and Mixers
6.2.7 Plasma Fractionation
6.2.8 Chromatography
6.2.9 Bio-therapeutic Molecule Production
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioprocessing Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioprocessing Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bioprocessing Systems Analysis and Forecast
9.1 Introduction
9.2 North America Bioprocessing Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bioprocessing Systems Market Size Forecast by Type
9.6.1 Upstream
9.6.2 Downstream
9.6.3 Single Use
9.6.4 Integrated
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bioprocessing Systems Market Size Forecast by Applications
9.10.1 Vaccine Development
9.10.2 Cell Therapy and Plant Cell Cultivation
9.10.3 Filters
9.10.4 Tissue Engineering
9.10.5 Biosensors
9.10.6 Bioreactors and Mixers
9.10.7 Plasma Fractionation
9.10.8 Chromatography
9.10.9 Bio-therapeutic Molecule Production
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bioprocessing Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Bioprocessing Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bioprocessing Systems Market Size Forecast by Type
10.6.1 Upstream
10.6.2 Downstream
10.6.3 Single Use
10.6.4 Integrated
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bioprocessing Systems Market Size Forecast by Applications
10.10.1 Vaccine Development
10.10.2 Cell Therapy and Plant Cell Cultivation
10.10.3 Filters
10.10.4 Tissue Engineering
10.10.5 Biosensors
10.10.6 Bioreactors and Mixers
10.10.7 Plasma Fractionation
10.10.8 Chromatography
10.10.9 Bio-therapeutic Molecule Production
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bioprocessing Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bioprocessing Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bioprocessing Systems Market Size Forecast by Type
11.6.1 Upstream
11.6.2 Downstream
11.6.3 Single Use
11.6.4 Integrated
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bioprocessing Systems Market Size Forecast by Applications
11.10.1 Vaccine Development
11.10.2 Cell Therapy and Plant Cell Cultivation
11.10.3 Filters
11.10.4 Tissue Engineering
11.10.5 Biosensors
11.10.6 Bioreactors and Mixers
11.10.7 Plasma Fractionation
11.10.8 Chromatography
11.10.9 Bio-therapeutic Molecule Production
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bioprocessing Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Bioprocessing Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bioprocessing Systems Market Size Forecast by Type
12.6.1 Upstream
12.6.2 Downstream
12.6.3 Single Use
12.6.4 Integrated
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bioprocessing Systems Market Size Forecast by Applications
12.10.1 Vaccine Development
12.10.2 Cell Therapy and Plant Cell Cultivation
12.10.3 Filters
12.10.4 Tissue Engineering
12.10.5 Biosensors
12.10.6 Bioreactors and Mixers
12.10.7 Plasma Fractionation
12.10.8 Chromatography
12.10.9 Bio-therapeutic Molecule Production
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bioprocessing Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bioprocessing Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bioprocessing Systems Market Size Forecast by Type
13.6.1 Upstream
13.6.2 Downstream
13.6.3 Single Use
13.6.4 Integrated
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bioprocessing Systems Market Size Forecast by Applications
13.10.1 Vaccine Development
13.10.2 Cell Therapy and Plant Cell Cultivation
13.10.3 Filters
13.10.4 Tissue Engineering
13.10.5 Biosensors
13.10.6 Bioreactors and Mixers
13.10.7 Plasma Fractionation
13.10.8 Chromatography
13.10.9 Bio-therapeutic Molecule Production
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioprocessing Systems Market: Competitive Dashboard
14.2 Global Bioprocessing Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lonza
14.3.2 Pall Corporation
14.3.3 GE Healthcare
14.3.4 Nordson MEDICAL's
14.3.5 Thermo Fisher Scientific
14.3.6 EMD Millipore Corporation
14.3.7 PBS Biotech
